Albany, NY -- (SBWIRE) -- 07/18/2014 -- GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape United Arab Emirates. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the UAE, identifying key trends in its healthcare market and providing insights into its demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

To view the table of contents for this market research report please visit : http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-united-arab-emirates-report.html

In 2013, the UAEs population stood at 9 million, an increase from 8.1 million in 2008. The countrys pharmaceutical market was estimated to have been worth $2.4 billion in 2013 and is expected to reach $3.7 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 5.3%. The UAEs medical device market was valued at approximately $600.2m in 2008, and $733.3m in 2013. The medical device market is estimated to reach $978.9m in 2020 at a CAGR of 4.2% from 2014.

The positive trends in UAEs healthcare market can primarily be attributed to the increasing coverage of healthcare insurance and government initiatives to improve healthcare facilities

Scope

Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers

Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Julphar, Neopharma, Pfizer, GlaxoSmithKline and Novartis. The key players covered for the medical devices market are Medtronic, Siemens Healthcare, F. Hoffmann-La Roche, Abbott Laboratories and Boston Scientific Corporation.

An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the healthcare market

Get full access to the report at : http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-united-arab-emirates-report.html

Reasons to buy

The report will enhance your decision-making capability by allowing you to

Develop business strategies through an understanding of the trends shaping and driving the healthcare market

Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership

Identify, understand and capitalize on the opportunities and challenges in the healthcare market

View similar market studies by Global data: http://www.researchmoz.us/pharmaceutical-market-reports-38.html